Succeed with Sirion – Transduction Enhancer LentiBOOST®

videosSIRION Biotech GmbH
December 16th 2021
A study by Vania Lo Presti and her colleagues shows efficient gene modification of CB CD8+ T cells using LV to potentially generate off-the-shelf T cell therapy products for cancer treatment. SIRION’s LentiBOOST® was proven a non-toxic transduction enhancer of CB CD8+ T cells in this study published in the Molecular Therapy – Methods and Clinical Development journal:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications